CN101973946A - Phenazine-1-carboxylic acids derivative and preparation method thereof - Google Patents

Phenazine-1-carboxylic acids derivative and preparation method thereof Download PDF

Info

Publication number
CN101973946A
CN101973946A CN 201010509746 CN201010509746A CN101973946A CN 101973946 A CN101973946 A CN 101973946A CN 201010509746 CN201010509746 CN 201010509746 CN 201010509746 A CN201010509746 A CN 201010509746A CN 101973946 A CN101973946 A CN 101973946A
Authority
CN
China
Prior art keywords
phenazine
carboxylic acid
compound
acid series
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 201010509746
Other languages
Chinese (zh)
Other versions
CN101973946B (en
Inventor
李荣秀
叶龙
许煜泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jiaotong University
Original Assignee
Shanghai Jiaotong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jiaotong University filed Critical Shanghai Jiaotong University
Priority to CN 201010509746 priority Critical patent/CN101973946B/en
Publication of CN101973946A publication Critical patent/CN101973946A/en
Application granted granted Critical
Publication of CN101973946B publication Critical patent/CN101973946B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a phenazine-1-carboxylic acids derivative and a preparation method thereof in the field of biotechnology. In the derivative, chemical groups, containing hydrophilic groups, hydrophobic groups, linear structure groups, cyclic structure groups and aromatic structure groups are introduced into 1-locus carboxyl of phenazine-1-carboxylic acid. The preparation method comprises the following steps of: reflowing and distilling the phenazine-1-carboxylic acid separated from pseudomonas in a thionyl chloride solution to obtain an activated intermediate; dissolving the activated intermediate into dichloromethane, and adding an amino compound and triethylamine under an ice bath; then reacting at room temperature to stay overnight, and following the reaction by using a thin layer chromatography; and rotatably evaporating, extracting, drying and purifying to obtain a target compound. The derivative is used as an active ingredient of a pesticide formulation for fighting fruit and vegetables and crop diseases and insect pests as well as rice sheath blight. In the invention, antifungal activity tests are carried out by utilizing a plate method, and the compound with better activity is obtained.

Description

Phenazine-1-carboxylic acid series derivates and preparation method thereof
Technical field
The present invention relates to derivative of a kind of biological technical field and preparation method thereof, particularly a kind of have anti-mycotic activity compound phenazine-1-carboxylic acid series derivates and preparation method thereof.
Background technology
Shanghai Communications University takes the lead in using Pseudomonas fluorescens strain M18 exploitation to have wide spectrum; efficiently; safety and the biological pesticide that can effectively control fungoid root-rot and stem rot; name and be " Shen piperazine mycin "; its main component is a phenazine-1-carboxylic acid; since then; the blight of cucumber and watermelon; the climing rot of muskmelon; the chronic disease that gourd, fruit and vegetables such as the root rot of capsicum are difficult to cure has had the jinx; phenazine-1-carboxylic acid is to filter out isolated microbiotic in many strains autotrophic bacteria from crop rhizosphere soils; can suppress various crop disease fungal pathogenses by wide spectrum, the high-efficiency prevention and control disease be arranged than other medicament; promote the high crop yield high-quality; advantage such as preserve the ecological environment.Relevant patent documentation is as follows:
Patent of invention title: growth-promoting antagonistic bacterium M 18 for biologic agricultural chemical and preparation method thereof, patent documentation publication number: CN1340609.This patent for invention technical project has also been used new efficient screening, cultivation program, prepares to have simultaneously from plant rhizosphere soil to promote plant-growth and broad spectrum to suppress the growth-promoting antagonistic bacterium M 18 for biologic agricultural chemical of plant epiphyte venereal disease evil.The product of this patent for invention can suppress various plants pathogen growth such as melon didymella bryoniae, Rhizoctonia solani Kuhn and cucumber fusarium axysporum effectively, and the growth of plant seedlings is had obvious facilitation.
Patent of invention title: utilize antagonizing bacteria M 18 strain to prepare the method for sterilant, patent documentation publication number: CN1802927.This patent for invention technology is under substratum of optimizing and culture condition, utilize derivative strain M18G and the M18R of growth-promoting antagonistic bacterium M18, produce the fermented liquid of high-content phenazine-1-carboxylic acid and pyoluteorin respectively, respectively M18G fermented liquid and M18R fermented liquid are prepared into dry powder again, and be that 90%~10% and 10%~90% to carry out physics composite with the weight percent of the pyoluteorin in phenazine-1-carboxylic acid in the M18G dry powder and the M18R dry powder, be prepared into the microbial source sterilant of high-efficiency prevention and control Plant diseases.The sterilant that this patent for invention provides is to be the wettable powder of activeconstituents but not active bacteria formulation with the microbial metabolites, thereby has a high stability, its drug effect is not subject to the influence of envrionment conditions, simultaneously under the prerequisite that low dosage uses, the multiple diseases of plant had higher prevention effect.
Patent of invention title: the RNA rapid extracting method of pseudomonas M 18, patent documentation publication number: CN101302508.The rapid extracting method of this patent for invention technology comprises that step is as follows: collects 106~107 cell pseudomonas M 18s, adds sex change liquid and chloroform, and mixing, centrifugal, bacterium liquid is divided into three layers in pipe; Draw 500 μ l supernatant liquids and be transferred in the silicon fiml post, and add Virahol, centrifugal; Add ethanol to the silicon fiml post, centrifugal; Repeat previous step; Centrifugal again, guarantee absence of liquid in the silicon fiml post; Add distilled water, elutriant to the silicon fiml post; Centrifugal, collect elutriant with a clean centrifuge tube.Extraction time of the present invention shortens greatly, from the method for extracting RNA as can be seen: the time of extraction is within 6min; There is not DNA to pollute; Leaching process is easy to automatization.After crossing column condition optimization, the RNA purity that extracts is very high; Its light absorption value of the RNA A260/A280=1.93 that extracts by spectrophotometric determination.
Application for a patent for invention title: utilize engineering bacterial strain M 18 G to carry plasmid pME 6032 Phz to produce the method for phenazine-1-carboxylic acid, patent documentation publication number: CN101705265A.This application for a patent for invention discloses and amplified the biosynthetic encoding gene fragment of phenazine-1-carboxylic acid phzA1-G1 from growth-promoting antagonistic bacterium M18 genome, and with among this gene fragment insertion expression plasmid pME6032, place under the control of strong promoter Ptac, be built into recombinant plasmid pME6032Phz; Then this recombinant plasmid is imported among the derivative strain M18G of growth-promoting antagonistic bacterium M18, be built into engineering strain M18G/pME6032Phz.This project bacterial strain is realized the high efficiency stable expression of encoding gene in the copy number of amplification phenazine-1-carboxylic acid biosynthesizing encoding gene.At last engineering strain M18G/pME6032Phz is cultivated in the analysis for soybean powder nutrient solution, produce phenazine-1-carboxylic acid efficiently and stably, significantly improve the output of phenazine-1-carboxylic acid.Utilize high-yield genetic engineering bacterium strain of the present invention to prepare phenazine-1-carboxylic acid, it produces instinct and reaches this requirement of farming that is applied to prevent and treat rice sheath blight disease, can be used for the preparation of sterilant Shen piperazine mycin, on a large scale controlling plant diseases.
In order to improve the activity of phenazine-1-carboxylic acid, reduce using dosage, it is the problem that current this technology improves and development faces that further searching has stronger active compound than phenazine-1-carboxylic acid.
Summary of the invention
The objective of the invention is to overcome deficiency of the prior art, a kind of phenazine-1-carboxylic acid series derivates and preparation method thereof is provided.The present invention carries out structural modification to phenazine-1-carboxylic acid, utilizes the reactivity of its 1 carboxyl, carries out condensation with different aminocompounds, can obtain the derivative of a series of phenazine-1-carboxylic acids, then, utilize flat band method to carry out the anti-mycotic activity test, obtained to have better active compound.
The present invention is achieved by the following technical solutions:
The present invention relates to the phenazine-1-carboxylic acid series derivates, by on 1 carboxyl of phenazine-1-carboxylic acid, introducing the chemical group that comprises hydrophilic radical, hydrophobic grouping, linear structure group and ring texture group, aromatic structure group, obtain having the target product of anti-mycotic activity through condensation reaction:
Figure BDA0000028610080000031
The compound 1-19 structural formula that generates is as follows:
Figure BDA0000028610080000032
Described chemical group comprises: methoxy ethamine; the N-acetylethylenediamine; the 3-alanine, N-(2 '-amino-ethyl) tetramethyleneimine, the 3-(propylamine of 2 '-oxo-pyrrolidine-1 '-yl); 3-(1H-imidazoles-1-yl) propylamine; 2-(ethamine of pyridine-2 '-yl), 2,4 difluorobenzene amine; the 2-phenyl-ethyl amine; suberane amine, 2-[2-(2-amino ethoxy) oxyethyl group] ethamine, 2-(4 '-p-methoxy-phenyl) ethamine; 2-(4 '-amino-sulfonyl phenyl) ethamine; pentamethylene amine, amantadine, benzylamine; cyclooctylamine, amino propylene of 3-and 3-(diethylamino) propylamine.
Described compound 1-19 by introduce hydrophilic chemical group on 1 carboxyl of phenazine-1-carboxylic acid, obtains having the active compound of stronger anti-rice sheath blight disease germ.
Described compound 1-19 by introduce the hydrophilic ring texture group that has on 1 carboxyl of phenazine-1-carboxylic acid, obtains having the active compound of stronger anti-rice sheath blight disease germ.
The invention still further relates to the preparation method of aforesaid phenazine-1-carboxylic acid series derivates, may further comprise the steps:
1. will from pseudomonas, in sulfur oxychloride solution, reflux and distill by isolated phenazine-1-carboxylic acid, obtain activated intermediate.
Described backflow and distillation, return time are 6 hours, and return time is to remove sulfur oxychloride with distillating method after 6 hours.
2. activated intermediate is dissolved in methylene dichloride, ice bath adds aminocompound and triethylamine down; Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.
Described aminocompound is an equivalent or 0.5 equivalent; Described triethylamine is four equivalents.
3. with revolving steaming, extraction, drying and purifying, obtain target compound.
Step is revolved steaming, extraction, drying and purifying described in 3., and its method is as follows:
A, with revolve steam to remove desolvate after, add ethyl acetate and water in the solid product to dissolving fully;
Organic layer is obtained in b, extraction repeatedly;
C, add anhydrous sodium sulfate drying in the organic layer and spend the night;
D, remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound through column chromatography purification; Through characterizing compounds, confirm as target compound.
Described ethyl acetate and water, its volume ratio is: 2: 1.
The invention still further relates to the application of aforesaid phenazine-1-carboxylic acid series derivates:
Application one, phenazine-1-carboxylic acid series derivates are used as the active ingredient of anti-gourd, fruit and vegetable and diseases and pests of agronomic crop pesticide preparation;
Application two, phenazine-1-carboxylic acid series derivates are used as the active ingredient of the pesticide preparation of anti-rice sheath blight disease.
The present invention adopts flat band method to carry out the anti-mycotic activity test.With the comparatively serious rice sheath blight disease germ (Rhizoctonia solani Kuhn) of influence in the farm crop is example, carries out active testing.Its implementation process is as follows:
1) preparation of bacterium piece to be measured: the PDA substratum that will dissolve is evenly poured in sterilized a few cover culture dish and is made flat board; Get one of germ bacterial classification, put into above-mentioned culture dish central authorities with aseptic technique picking one fritter, be inverted in 28 ℃ of incubators and cultivate, mycelia is covered with flat board, and this moment can be for using (attention cell age unanimity).
2) mother liquor configuration: in anhydrous ethanol solvent, concentration is arranged to Geometric Sequence with sample dissolution, about five.
3) times dilution methods such as preparation method's one substratum of pastille culture medium flat plate: get the mother liquor of equivalent, add 60mL PDA substratum, pour in the three cover culture dish preparation pastille flat board after fully shaking up into; Get the not PDA substratum of pastille of 50mL again, evenly pour three cover culture dish into, make blank.
4) connecing bacterium measures: after treating the substratum cooled and solidified, insert the pathogenic bacteria bacterium cake of diameter 0.8cm; The culture dish that connects kind is inverted in 28 ℃ the incubator and cultivates; After treating that blank covers with (about about 42h), measure the colony diameter that each is handled, calculate bacteriostasis rate then with the right-angled intersection method.
5) data processing: the method for calculation of bacteriostasis rate: bacteriostasis rate=1-(D t/ D Ck), D tExpression specimen flat-plate bacterial colony diameter, D CkExpression blank flat-plate bacterial colony diameter; Half-inhibition concentration waits the regression equation calculation of the bacteriostasis rate of specific concentration to draw according to five.
The present invention is an example with the rice sheath blight disease germ, enumerates the Mlc (seeing Table 1) of part of compounds.Cited compound has all showed certain activity, and wherein compound 7,9, and 10 have shown better biological activity.These will be as the further derivative synthetic of the present invention foundation.Table 1 phenazine-1-carboxylic acid derivative anti-mycotic activity is as follows:
Figure BDA0000028610080000051
Figure BDA0000028610080000061
Can obviously find out from last table, compound 7,9,10 have shown better anti-rice sheath blight disease germ activity.With compound 10 is example, its anti-rice sheath blight disease germ IC 50Be 0.003 μ M, and phenazine-1-carboxylic acid is 0.068 μ M, the latter is the former more than 20 times.That is to say that will reach same anti-rice sheath blight disease germ effect, the dosage of compound 10 only needs 1/20th of phenazine-1-carboxylic acid.Therefore, compare phenazine-1-carboxylic acid, the activity of compound 10 improves greatly, and the using dosage that reaches same antimycotic effectiveness just can reduce greatly.
In all former document of biomaterial pseudomonas that the present invention relates to and rice sheath blight disease germ more report is arranged.Pseudomonas, lifting one piece is example, Xu Yuquan at the 2004 FEMS MICROBIOLOGY LETTERS that publish the 237th volume, just once set forth the mechanism of pseudomonas metabolism phenazine-1-carboxylic acid as the communication author in the 41-47 page or leaf.Sheath and culm blight of rice germ, lifting one piece is example, the Soil Biology﹠amp that Yulianti T etc. published in 2006; Biochemistry the 38th volume 923-930 page or leaf was just once set forth the rice sheath blight disease germ.
Embodiment
Below embodiments of the invention are elaborated: following examples are being to implement under the prerequisite with the technical solution of the present invention, detailed embodiment and process have been provided, but protection scope of the present invention is not limited to following embodiment, include but not limited to hydrophilic radical, hydrophobic grouping, linear structure group and ring texture group, aromatic structure group as the chemical group of introducing; The chemical group of introducing includes but not limited to methoxy ethamine, the N-acetylethylenediamine, the 3-alanine, N-(2 '-amino-ethyl) tetramethyleneimine, the 3-(propylamine of 2 '-oxo-pyrrolidine-1 '-yl), 3-(1H-imidazoles-1-yl) propylamine, 2-(ethamine of pyridine-2 '-yl), 2,4 difluorobenzene amine, the 2-phenyl-ethyl amine, suberane amine, 2-[2-(2-amino ethoxy) oxyethyl group] ethamine, 2-(4 '-p-methoxy-phenyl) ethamine, 2-(4 '-amino-sulfonyl phenyl) ethamine, pentamethylene amine, amantadine, benzylamine, cyclooctylamine, amino propylene of 3-and 3-(diethylamino) propylamine; The chemical group of 1 carboxyl introducing includes but not limited to hydrophilic radical, hydrophobic grouping, linear structure group and ring texture group, aromatic structure group.
In following examples, the experimental technique of unreceipted actual conditions, usually according to normal condition, or the condition of advising according to manufacturer.
Embodiment 1
Synthesizing of compound N-(2 '-methoxy ethyl) azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down methoxy ethamine (equivalent, 150.2mg, 0.170mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-(2 '-methoxy ethyl) azophenlyene-1-methane amide 338.2mg through column chromatography purification, productive rate is 60.1%.Yellow solid .mp:98-99 ℃ .IR (KBr compressing tablet): 3441,3263,2964,2921,2810,1666,1557,1416,1347,1263,1193,1118,1087,1028,875,841,796,747,694cm -1. 1H NMR (300MHz, CDCl 3): δ 11.35 (m, 1H), 9.00 (m, 1H), 8.38 (m, 1H), 8.25 (m, 2H), 7.94 (m, 3H), 3.89 (m, 2H), 3.75 (m, 2H) and 3.55 (s, 3H). 13C NMR (100MHz, DMSO-d 6): δ 163.7,142.3,142.2,140.6,139.7,134.1,132.9,132.0,131.4,130.0,129.3,129.0,128.6,70.4,58.0.HRMS (ESI positive mode): theoretical value [M+H] +282.1243, experimental value 282.1239.
Embodiment 2
Synthesizing of compound N-(2 '-kharophen ethyl) azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down the N-acetylethylenediamine (equivalent, 204mg, 0.232mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-(2 '-kharophen ethyl) azophenlyene-1-methane amide 301.6mg through column chromatography purification, productive rate is 48.9%.Yellow powder .Mp:156-157 ℃ .IR (KBr compressing tablet): 3447,2960,2927,2077,1651,1562,1416,1262,1096,1025,803,752,661,591cm -1. 1H NMR (300MHz, CDCl 3): δ 11.25 (m, 1H), 8.97 (m, 1H), 8.41 (m, 1H), 8.28 (m, 2H), 7.95 (m, 3H), 6.60 (m, 1H), 3.84 (m, 2H), 3.65 (m, 2H) and 2.01 (s, 3H). 13C NMR (100MHz, CDCl 3): δ 170.7,166.2,143.3,143.0,141.2,140.5,135.3,134.0,131.9,131.1,129.8,129.7,129.0,128.5,40.8,39.5,23.3.HRMS (ESI positive mode): theoretical value [M+H] +309.1352, experimental value 309.1342.
Embodiment 3
Synthesizing of compound N-(3 '-carboxyl propyl group) azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down the 3-alanine (equivalent, 103mg) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-(3 '-carboxyl propyl group) azophenlyene-1-methane amide 105.0mg through column chromatography purification, productive rate is 17.0%.Yellow solid .Mp:141-142 ℃ .IR (KBr compressing tablet): 3443,2925,2859,1719,1645,1561,1464,1415,1261,1225,1095,1023,861,801,751,669cm -1. 1H NMR (300MHz, CDCl 3): δ 11.20 (m, 1H), 8.97 (m, 1H), 8.53 (m, 1H), 8.30 (m, 2H), 7.98 (m, 3H), 3.78 (m, 2H), 2.60 (t, J=4.2,2H) and 2.15 (m, 2H). 13C NMR (100MHz, CDCl 3): δ 176.8,165.9,143.9,142.7,141.1,137.3,135.0,133.2,131.7,131.1,130.2,129.9,129.4,127.9,39.0,31.9,25.1.HRMS (ESIpositive mode): theoretical value [M+H] +310.1192, experimental value 310.1199.
Embodiment 4
Compound N-[2 '-(tetramethyleneimine-1 "-yl) ethyl] azophenlyene-1-methane amide synthetic
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down N-(2 '-amino-ethyl) tetramethyleneimine (equivalent, 228mg, 0.253mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, through column chromatography purification obtain target compound N-[2 '-(tetramethyleneimine-1 "-yl) ethyl] azophenlyene-1-methane amide 527.7mg, productive rate is 82.4%.Yellow powder .Mp:126-127 ℃ .IR (KBr compressing tablet): 3445,2959,2795,1653,1562,1526,1416,1349,1266,1021,798,750,702cm -1. 1H NMR (300MHz, CDCl 3): δ 11.35 (m, 1H), 9.00 (m, 1H), 8.39 (m, 1H), 8.29 (m, 2H), 7.94 (m, 3H), 3.86 (m, 2H), 2.95 (m, 2H), 2.78 (m, 4H) and 1.93 (m, 4H). 13C NMR (100MHz, CDCl 3): δ 164.7,143.4, and 142.9,141.4,140.9,135.1,133.4,131.3 130.9,130.0,129.6,129.3,129.1,54.9,54.1,39.1,23.7.HRMS (ESI positive mode): theoretical value [M+H] +321.1715, experimental value 321.1730.
Embodiment 5
Compound N-[3 '-(2 "-oxo-pyrrolidine-1 "-yl) propyl group] azophenlyene-1-methane amide synthetic
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down 3-(propylamine of 2 '-oxo-pyrrolidine-1 '-yl) (and an equivalent, 284.4mg, 0.280mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, through column chromatography purification obtain target compound N-[3 '-(2 "-oxo-pyrrolidine-1 "-yl) propyl group] azophenlyene-1-methane amide 637.4mg, productive rate is 91.5%.Brown solid .Mp:101-102 ℃ .IR (KBr compressing tablet): 3445,3228,2925,2921,2810,1736,1674,1649,1524,1462,1428,1376,1346,1262,1155,1094,1024,809,752,692cm -1. 1H NMR (300MHz, CDCl 3): δ 11.18 (s, 1H), 8.98 (m, 1H), 8.54 (m, 1H), 8.38 (m, 1H), 8.26 (m, 1H), 7.93 (m, 3H), 3.68 (m, 2H), 3.54 (t, J=3.6,2H), 3.46 (t, J=3.9,2H) 2.42 (t, J=7.8,2H) and 2.02 (m, 4H). 13C NMR (100MHz, CDCl 3): δ 175.2,164.7,143.0,142.7,141.3,140.5,134.9,133.4,131.5,130.8,129.6,129.3,129.2,128.9,47.0,40.2,37.0,30.8,27.2,17.8.HRMS (ESI positive mode): theoretical value [M+H] +349.1665, experimental value 349.1667.
Embodiment 6
Synthesizing of compound N-[3 '-(1H-imidazoles-1-yl) propyl group] azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down 3-(1H-imidazoles-1-yl) propylamine (equivalent, 250mg, 0.236mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-[3 '-(1H-imidazoles-1-yl) propyl group through column chromatography purification] azophenlyene-1-methane amide 547.2mg, productive rate is 82.6%.Yellow powder .Mp:136-137 ℃ .IR (KBr compressing tablet): 3444,2960,1651,1560,1520,1415,1266,1230,1082,1027,902,799,748,696,662,624cm -1. 1H NMR (300MHz, CDCl 3): δ 11.12 (m, 1H), 9.00 (m, 1H), 8.41 (m, 1H), 8.26 (m, 2H), 7.96 (m, 3H), 7.60 (s, 1H), 7.06 (d, J=20.7,2H), 4.17 (t, J=3.9,2H), 3.67 (m, 2H) and 3.30 (m, 2H). 13C NMR (100MHz, CDCl 3): δ 164.9,143.1,142.7,140.8,140.3,137.0,135.2,133.6,131.7,130.8,129.7,129.5,129.4,128.5,128.4,118.7,44.4,36.6,30.9.HRMS (ESI positive mode): theoretical value [M+H] +332.1511, experimental value 332.1521.
Embodiment 7
Compound N-[2 '-(pyridine-2 "-yl) ethyl] azophenlyene-1-methane amide synthetic
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down 2-(ethamine of pyridine-2 '-yl) (and an equivalent, 244.3mg, 0.238mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, through column chromatography purification obtain target compound N-[2 '-(pyridine-2 "-yl) ethyl] azophenlyene-1-methane amide 634.2mg, productive rate is 96.6%..Mp:83-84 ℃ of .IR of red-brown solid (KBr compressing tablet): 3445,2960,2103,1659,1589,1561,1523,1470,1426,1351,1263,1096,1024,870,805,750,702,671,507cm -1. 1H NMR (300MHz, CDCl 3): δ 11.14 (s, 1H), 8.99 (m, 1H), 8.63 (m, 1H), 8.35 (m, 1H), 8.24 (m, 1H), 7.93 (m, 4H), 7.59 (m, 1H), 7.29 (s, 1H), 7.16 (m, 1H), 4.13 (m, 2H) and 3.29 (t, J=3.6,2H). 13C NMR (100MHz, CDCl 3): δ 164.6,159.5,149.3,143.1,142.6,141.0,140.5,136.4,135.1,133.3,131.2,130.7,129.8,129.4,128.9,123.4,121.4,39.3,37.7.HRMS (ESI positive mode): theoretical value [M+H] +329.1402, experimental value 329.1409.
Embodiment 8
Synthesizing of compound N-(2 ', 4 '-difluorophenyl) azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down 2,4 difluorobenzene amine (equivalent, 258mg, 0.202mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-(2 ', 4 '-difluorophenyl) azophenlyene-1-methane amide 118.6mg through column chromatography purification, productive rate is 17.7%.Yellow powder .Mp:212-213 ℃ .IR (KBr compressing tablet): 3443,2964,1679,1618,1565,1425,1259,1095,1023,961,841,803,752,725cm -1. 1H NMR (300MHz, CDCl 3): δ 9.05 (m, 1H), 8.77 (m, 1H), 8.45 (m, 1H), 8.33 (m, 2H), 7.98 (m, 4H), 7.00 (m, 2H). 13CNMR (100MHz, DMSO-d 6): δ 163.2,162.6,143.0,142.8,142.6,134.0,132.9,132.8,132.0,131.9,131.2,130.7,129.4,129.2,128.0,125.0,122.2,111.1,104.2.HRMS (ESI positive mode): theoretical value [M+H] +336.0948, experimental value 336.0942.
Embodiment 9
Synthesizing of compound N-phenylethyl azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down the 2-phenyl-ethyl amine (equivalent, 242mg, 0.251mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-phenylethyl azophenlyene-1-methane amide 464.9mg through column chromatography purification, productive rate is 71.0%.Yellow powder .Mp:93-94 ℃ .IR (KBr compressing tablet): 3454,3235,3059,2964,2925,2878,1657,1616,1551,1520,1346,1263,1204,1164,1093,1029,960,924,862,818,747,697,664,578,519cm -1. 1H NMR (300MHz, CDCl 3): δ 11.02 (s, 1H), 9.01 (m, 1H), 8.30 (m, 2H), 7.89 (m, 3H), 7.65 (m, 1H), 7.34 (m, 5H), 4.03 (m, 2H) and 3.10 (d, J=3.6,2H). 13C NMR (100MHz, CDCl 3): δ 164.6,143.1,142.7,140.9,140.5,139.5,135.2,133.4,131.2,130.8,129.8,129.4,129.0,128.9,128.8,128.6,126.3,40.7,35.7.HRMS (ESI positive mode): theoretical value [M+H] +328.1450, experimental value 328.1458.
Embodiment 10
Synthesizing of compound N-suberane base azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down suberane amine (equivalent, 226mg, 0.255mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-suberane base azophenlyene-1-methane amide 564.7mg through column chromatography purification, productive rate is 88.4%.Yellow powder .Mp:126-127 ℃ .IR (KBr compressing tablet): 3445,3257,2922,2853,1658,1619,1554,1523,1455,1417,1349,1263,1210,1098,1022,805,745,676cm -1. 1H NMR (300MHz, CDCl 3): δ 11.11 (m, 1H), 9.00 (m, 1H), 8.37 (m, 1H), 8.29 (m, 1H), 8.20 (m, 1H), 7.94 (m, 3H), 4.44 (m, 1H), 2.15 (m, 2H) and 1.84 (m, 10H). 13C NMR (100MHz, CDCl 3): δ 163.2,143.6,142.7,141.0,140.7,135.1,133.2,131.4,130.7,129.9,129.5,129.2,128.7,50.5,34.7,28.1,24.1.HRMS (ESI positive mode): theoretical value [M+H] +320.1763, experimental value 320.1766.
Embodiment 11
Compound 1,2-two (N-phenazinyl carbonyl-2 '-amino ethoxy) ethane synthetic
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, and ice bath adds down 2-[2-(2-amino ethoxy) oxyethyl group] ethamine (0.5 equivalent, 148.2mg, 0.147mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound 1 through column chromatography purification, 2-two (N-phenazinyl carbonyl-2 '-amino ethoxy) ethane 139.3mg, productive rate is 12.4%..Mp:112-113 ℃ of .IR of red-brown solid (KBr compressing tablet): 3444,2962,2913,2817,1655,1546,1468,1414,1346,1261,1097,1024,867,801,751,699,602cm -1. 1H NMR (300MHz, CDCl 3): δ 11.10 (s, 2H), 8.75 (m, 4H), 8.13 (m, 2H), 7.82 (m, 4H), 7.70 (m, 2H), 7.57 (m, 2H) and 3.88 (m, 12H). 13C NMR (100MHz, CDCl 3): δ 164.3,142.4,141.9,140.4,139.7,134.8,133.3,131.0,130.6,129.4,128.8,128.7,128.2,70.7,70.1,39.6.HRMS (ESI positive mode): theoretical value [M+H] +561.2250, experimental value 561.2241.
Embodiment 12
Synthesizing of compound N-(4 '-p-methoxy-phenyl ethyl) azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down 2-(4 '-p-methoxy-phenyl) ethamine (equivalent, 302.4mg, 0.293mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-(4 '-p-methoxy-phenyl ethyl) azophenlyene-1-methane amide 502.8mg through column chromatography purification, productive rate is 70.3%.Yellow powder. 1H?NMR(300MHz,CDCl 3):δ10.99(s,1H),9.00(m,1H),8.35(m,1H),8.23(m,1H),7.88(m,3H),7.63(m,1H),7.29(m,2H),6.86(m,2H),4.03(dd,J1=12.3,J2=6.3,2H),3.79(s,3H)and?3.02(t,J=6.3,2H)。
Embodiment 13
Synthesizing of compound N-(4 '-amino-sulfonyl phenylethyl) azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down 2-(4 '-amino-sulfonyl phenyl) ethamine (equivalent, 400.6mg) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-(4 '-amino-sulfonyl phenylethyl) azophenlyene-1-methane amide 802.8mg through column chromatography purification, productive rate is 98.7%.Yellow powder. 1H?NMR(300MHz,CDCl 3):δ11.08(s,1H),8.99(m,1H),8.38(m,5H),7.95(m,5H),7.59(m,2H),4.04(m,2H)and?3.17(m,2H)。
Embodiment 14
Synthesizing of compound N-pentamethylene base azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down pentamethylene amine (equivalent, 170.4mg, 0.198mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-pentamethylene base azophenlyene-1-methane amide 467.2mg through column chromatography purification, productive rate is 80.2%.Yellow powder. 1H?NMR(300MHz,CDCl 3):δ11.14(m,1H),9.00(d,J=7.2,1H),8.26(m,3H),7.93(m,3H),4.61(m,1H),2.16(m,2H)and?1.86(m,6H)。
Embodiment 15
Synthesizing of compound N-(1-adamantyl) azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down amantadine (equivalent, 175.4mg) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-(1-adamantyl) azophenlyene-1-methane amide 344.3mg through column chromatography purification, productive rate is 48.2%.Yellow powder. 1H?NMR(300MHz,CDCl 3):δ11.14(m,1H),8.96(m,1H),8.25(m,3H),7.96(m,3H),2.35(s,6H),2.20(s,3H)and?1.80(m,6H)。
Embodiment 16
Synthesizing of compound N-benzyl azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down benzylamine (equivalent, 214.3mg, 0.219mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-benzyl azophenlyene-1-methane amide 571.2mg through column chromatography purification, productive rate is 91.1%.Yellow powder. 1H?NMR(300MHz,CDCl 3):δ11.42(s,1H),9.03(m,1H),8.31(m,2H),7.93(m,4H),7.45(m,5H)and?4.90(d,J=5.1,2H)。
Embodiment 17
Synthesizing of compound N-ring octyl group azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down cyclooctylamine (equivalent, 254.5mg, 0.280mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-ring octyl group azophenlyene-1-methane amide 570.2mg through column chromatography purification, productive rate is 85.5%.Yellow powder. 1H?NMR(300MHz,CDCl 3):δ11.14(m,1H),8.99(m,1H),8.26(m,3H),7.93(m,3H),4.42(m,1H)and?1.91(m,14H)。
Embodiment 18
Compound N-(propylene-3 '-yl) azophenlyene-1-methane amide is synthetic
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down the amino propylene of 3-(equivalent, 114.2mg, 0.150mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, (azophenlyene-1-methane amide 390.3mg of propylene-3 '-yl), productive rate is 74.1% to obtain target compound N-through column chromatography purification.Yellow powder. 1H?NMR(300MHz,CDCl 3):δ11.13(m,1H),9.01(m,1H),8.28(m,3H),7.94(m,3H),6.15(m,1H),5.48(m,1H),5.29(m,1H)and?4.34(s,2H)。
Embodiment 19
Synthesizing of compound N-[3 '-(diethylamino) propyl group] azophenlyene-1-methane amide
448.4mg phenazine-1-carboxylic acid refluxes after 6 hours in 20mL sulfur oxychloride solution, distillation method is removed sulfur oxychloride, obtains the sulfoxide activated intermediate.Activated intermediate is dissolved in the 5mL methylene dichloride, ice bath add down 3-(diethylamino) propylamine (equivalent, 260.5mg, 0.318mL) and as the triethylamine of acid scavenger (four equivalents, 1.12mL).Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction.Steam except that after desolvating with revolving, in solid product, add ethyl acetate and water (volume ratio 2: 1) dissolving extremely fully.Extract repeatedly three times, get organic layer.Adding anhydrous sodium sulfate drying in the organic layer spends the night.Remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound N-[3 '-(diethylamino) propyl group through column chromatography purification] azophenlyene-1-methane amide 540.4mg, productive rate is 80.3%.Yellow solid. 1HNMR(300MHz,CDCl 3):
Figure BDA0000028610080000151
11.01(m,1H),9.00(m,1H),8.30(m,3H),7.95(m,3H),3.71(m,2H),2.69(m,2H),2.59(m,4H)1.97(m,2H)?and?1.04(t,J=7.2,6H)。

Claims (10)

1. phenazine-1-carboxylic acid series derivates, it is characterized in that, by on 1 carboxyl of phenazine-1-carboxylic acid, introducing the chemical group that comprises hydrophilic radical, hydrophobic grouping, linear structure group and ring texture group, aromatic structure group, obtain having the target product of anti-mycotic activity through condensation reaction:
Figure FDA0000028610070000011
The compound 1-19 structural formula that generates is as follows:
Figure FDA0000028610070000012
Figure FDA0000028610070000021
2. phenazine-1-carboxylic acid series derivates according to claim 1 is characterized in that, described chemical group comprises: methoxy ethamine; the N-acetylethylenediamine; the 3-alanine, N-(2 '-amino-ethyl) tetramethyleneimine, the 3-(propylamine of 2 '-oxo-pyrrolidine-1 '-yl); 3-(1H-imidazoles-1-yl) propylamine; 2-(ethamine of pyridine-2 '-yl), 2,4 difluorobenzene amine; the 2-phenyl-ethyl amine; suberane amine, 2-[2-(2-amino ethoxy) oxyethyl group] ethamine, 2-(4 '-p-methoxy-phenyl) ethamine; 2-(4 '-amino-sulfonyl phenyl) ethamine; pentamethylene amine, amantadine, benzylamine; cyclooctylamine, amino propylene of 3-and 3-(diethylamino) propylamine.
3. phenazine-1-carboxylic acid series derivates according to claim 1 is characterized in that, described compound 1-19 by introduce hydrophilic chemical group on 1 carboxyl of phenazine-1-carboxylic acid, obtains having the active compound of stronger anti-rice sheath blight disease germ.
4. phenazine-1-carboxylic acid series derivates according to claim 1, it is characterized in that, described compound 1-19 by introduce the hydrophilic ring texture group that has on 1 carboxyl of phenazine-1-carboxylic acid, obtains having the active compound of stronger anti-rice sheath blight disease germ.
5. the preparation method of a phenazine-1-carboxylic acid series derivates according to claim 1 is characterized in that, may further comprise the steps:
1. will from pseudomonas, in sulfur oxychloride solution, reflux and distill by isolated phenazine-1-carboxylic acid, obtain activated intermediate;
2. activated intermediate is dissolved in methylene dichloride, ice bath adds aminocompound and triethylamine down; Then, room temperature reaction spends the night, and uses thin layer chromatography to follow the tracks of reaction;
3. with revolving steaming, extraction, drying and purifying, obtain target compound.
6. the preparation method of phenazine-1-carboxylic acid series derivates according to claim 5 is characterized in that, backflow and the distillation of step described in 1., and return time is 6 hours, return time is to remove sulfur oxychloride with distillating method after 6 hours.
7. the preparation method of phenazine-1-carboxylic acid series derivates according to claim 5 is characterized in that, the aminocompound of step described in 2. is an equivalent or 0.5 equivalent; Described triethylamine is four equivalents.
8. the preparation method of phenazine-1-carboxylic acid series derivates according to claim 5 is characterized in that, step is revolved steaming, extraction, drying and purifying described in 3., and its method is as follows:
A, with revolve steam to remove desolvate after, add ethyl acetate and water in the solid product to dissolving fully, the volume ratio of ethyl acetate and water is: 2: 1;
Organic layer is obtained in b, extraction repeatedly;
C, add anhydrous sodium sulfate drying in the organic layer and spend the night;
D, remove by filter siccative, use Rotary Evaporators to remove to desolvate and obtain crude product, obtain target compound through column chromatography purification; Through characterizing compounds, confirm as target compound.
9. the application of a phenazine-1-carboxylic acid series derivates according to claim 1 is characterized in that, the phenazine-1-carboxylic acid series derivates is used as the active ingredient of anti-gourd, fruit and vegetable and diseases and pests of agronomic crop pesticide preparation.
10. the application of a phenazine-1-carboxylic acid series derivates according to claim 1 is characterized in that, the phenazine-1-carboxylic acid series derivates is used as the active ingredient of the pesticide preparation of anti-rice sheath blight disease.
CN 201010509746 2010-10-15 2010-10-15 Phenazine-1-carboxylic acids derivative and preparation method thereof Expired - Fee Related CN101973946B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010509746 CN101973946B (en) 2010-10-15 2010-10-15 Phenazine-1-carboxylic acids derivative and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010509746 CN101973946B (en) 2010-10-15 2010-10-15 Phenazine-1-carboxylic acids derivative and preparation method thereof

Publications (2)

Publication Number Publication Date
CN101973946A true CN101973946A (en) 2011-02-16
CN101973946B CN101973946B (en) 2012-12-12

Family

ID=43573864

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010509746 Expired - Fee Related CN101973946B (en) 2010-10-15 2010-10-15 Phenazine-1-carboxylic acids derivative and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101973946B (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102812956A (en) * 2012-09-18 2012-12-12 北京燕化永乐农药有限公司 Bactericidal composition
WO2013067719A1 (en) * 2011-11-07 2013-05-16 上海交通大学 Bioengineering strain for producing new microbial fungicide and use thereof
CN103155926A (en) * 2011-12-18 2013-06-19 深圳诺普信农化股份有限公司 Sterilization composite based on phenazino-1-carboxylicacid
CN103155925A (en) * 2011-12-18 2013-06-19 深圳诺普信农化股份有限公司 Sterilization composite containing phenazino-1-carboxylic acid
CN103343150A (en) * 2013-07-22 2013-10-09 上海农乐生物制品股份有限公司 Preparation method of phenazine-1-formylhydrazine biological germicide
CN103360329A (en) * 2013-07-18 2013-10-23 中国科学院南海海洋研究所 Phenazine compound and it application in preparation of anti-tumor drugs
CN103373967A (en) * 2013-07-08 2013-10-30 大连九信生物化工科技有限公司 Synthesis method of shenqinmycin
CN104045601A (en) * 2014-06-23 2014-09-17 南京工业大学 Method for synthesizing phenazine-1-carboxylic acid
CN104829544A (en) * 2014-02-08 2015-08-12 上海泰禾化工有限公司 Preparation method for phenazine-1-carboxylic acid
CN106632098A (en) * 2016-12-17 2017-05-10 长江大学 Phenazine-1-carboxylic acid carboxyl derivative and sterilization composition with derivative
CN107880035A (en) * 2017-11-07 2018-04-06 华南农业大学 1,3,4 thiophene (Evil of one kind) diazole azophenlyene 1 Carbox amide preparation method and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115394A2 (en) * 1983-01-21 1984-08-08 Merck Frosst Canada Inc. Phenothiazone derivatives and analogs
EP0172744A2 (en) * 1984-08-16 1986-02-26 Development Finance Corporation Of New Zealand Phenazinecarboxamide compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115394A2 (en) * 1983-01-21 1984-08-08 Merck Frosst Canada Inc. Phenothiazone derivatives and analogs
EP0172744A2 (en) * 1984-08-16 1986-02-26 Development Finance Corporation Of New Zealand Phenazinecarboxamide compounds

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013067719A1 (en) * 2011-11-07 2013-05-16 上海交通大学 Bioengineering strain for producing new microbial fungicide and use thereof
CN103155925B (en) * 2011-12-18 2014-04-23 深圳诺普信农化股份有限公司 Sterilization composite containing phenazino-1-carboxylic acid
CN103155926A (en) * 2011-12-18 2013-06-19 深圳诺普信农化股份有限公司 Sterilization composite based on phenazino-1-carboxylicacid
CN103155925A (en) * 2011-12-18 2013-06-19 深圳诺普信农化股份有限公司 Sterilization composite containing phenazino-1-carboxylic acid
CN102812956B (en) * 2012-09-18 2013-08-14 北京燕化永乐农药有限公司 Bactericidal composition
CN102812956A (en) * 2012-09-18 2012-12-12 北京燕化永乐农药有限公司 Bactericidal composition
CN103373967A (en) * 2013-07-08 2013-10-30 大连九信生物化工科技有限公司 Synthesis method of shenqinmycin
CN103360329A (en) * 2013-07-18 2013-10-23 中国科学院南海海洋研究所 Phenazine compound and it application in preparation of anti-tumor drugs
CN103360329B (en) * 2013-07-18 2015-11-18 中国科学院南海海洋研究所 One class compound phenazine and preparing the application in antitumor drug
CN103343150A (en) * 2013-07-22 2013-10-09 上海农乐生物制品股份有限公司 Preparation method of phenazine-1-formylhydrazine biological germicide
CN103343150B (en) * 2013-07-22 2015-10-07 上海农乐生物制品股份有限公司 A kind of preparation method of azophenlyene-1-formyl hydrazine biological bactericide
CN104829544A (en) * 2014-02-08 2015-08-12 上海泰禾化工有限公司 Preparation method for phenazine-1-carboxylic acid
CN104829544B (en) * 2014-02-08 2017-12-26 上海泰禾国际贸易有限公司 A kind of method for preparing the carboxylic acid of azophenlyene 1
CN104045601A (en) * 2014-06-23 2014-09-17 南京工业大学 Method for synthesizing phenazine-1-carboxylic acid
CN106632098A (en) * 2016-12-17 2017-05-10 长江大学 Phenazine-1-carboxylic acid carboxyl derivative and sterilization composition with derivative
CN107880035A (en) * 2017-11-07 2018-04-06 华南农业大学 1,3,4 thiophene (Evil of one kind) diazole azophenlyene 1 Carbox amide preparation method and application
CN107880035B (en) * 2017-11-07 2021-05-28 华南农业大学 Preparation method and application of 1,3, 4-thia (oxa) diazole-phenazine-1-formamide compound

Also Published As

Publication number Publication date
CN101973946B (en) 2012-12-12

Similar Documents

Publication Publication Date Title
CN101973946B (en) Phenazine-1-carboxylic acids derivative and preparation method thereof
WO2021068556A1 (en) Rice blast fungicide prepared using lysinibacillus boronitolerans as chassis cell
Illescas et al. Phytohormone production profiles in Trichoderma species and their relationship to wheat plant responses to water stress
Zhuang et al. Effects of nitrogen and phosphorus concentrations on the growth of microalgae Scenedesmus. LX1 in suspended-solid phase photobioreactors (ssPBR)
CN102276596B (en) Thiadiazole compound as well as preparation and application thereof
Sajid et al. Identification, isolation and optimization of antifungal metabolites from the Streptomyces Malachitofuscus ctf9
Yue et al. The screening and identification of the biological control fungi Chaetomium spp. against wheat common root rot
CN103664808A (en) Aryl triazole compound containing chlorinated cyclopropane and preparation method and application thereof
Chen et al. Research advances in the mutual mechanisms regulating response of plant roots to phosphate deficiency and aluminum toxicity
CN102936252A (en) Sesterterpine compounds, and preparation method and application thereof
Sumalan et al. P-aminobenzoate organic salts as potential plant growth regulators for tomatoes
Mahdi et al. Bacillus velezensis QA2 potentially induced salt stress tolerance and enhanced phosphate uptake in quinoa plants
CN108558850B (en) Bactericide containing thiophene ring and stilbene amide, and preparation method and application thereof
CN102718731B (en) 4 /5-methyl-1, 2, 3-thiadiazole formic acid derivative and preparation method thereof
CN110343705A (en) It is a kind of regulation tomato ascorbic acid accumulation NBS-LRR gene and its application
JP2013180995A (en) Carbonic acid ester extract from angleworm fecal soil and method for production thereof
CN102850342B (en) Oxdiazole compound containing thiadiazole, preparation method and applications thereof
CN105399713B (en) New benzene peptide derivant and its preparation method and application
Liu et al. Proteomic insight into the symbiotic relationship of Pinus massoniana Lamb and Suillus luteus towards developing Al-stress resistance
CN104059044A (en) Xanthone derivative and preparation method and application of xanthone derivative
CN103275073B (en) 2-(1,2,4-triazole-1-methyl)-2-(cumarone-5-base)-DOX and application thereof
Kang et al. Growth and photosynthetic characteristics of sesame seedlings with gibberellin-producing Rhodobacter sphaeroides SIR03 and biochar
CN103141486B (en) Application of 4-(benzofuran-5-yl)-2-phenzyl aminothiazole as bactericide
CN102180857A (en) Xanthene derivative, and preparation method and application thereof
CN1371607A (en) Medicine for resisting rice blast, its preparation method and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121212

Termination date: 20151015

EXPY Termination of patent right or utility model